Flash Glucose Monitoring Industry - Regional Synopsis
Regionally, the global flash glucose monitoring market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America industry is estimated to hold largest revenue share of 40% by 2037 backed by the changing lifestyle, rising prevalence of obesity, rising healthcare expenditure, and increasing cases of diabetes in the region. As per the Centers for Disease Control and Prevention (CDC), the total number of people in United States who have been suffering from diabetes has reached 37.3 million by the January 2022.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of flash glucose monitoring is evaluated at USD 16.61 million.
The flash glucose monitoring market size was over USD 15.53 million in 2024 and is projected to reach USD 45.94 million by 2037, growing at around 8.7% CAGR during the forecast period i.e., between 2025-2037. Worldwide rising incidences of chronic diseases, and growing improvement in glycemia in higher risk patients with the use of flash glucose monitoring, will drive the market growth.
North America industry is estimated to hold largest revenue share of 40% by 2037, backed by changing lifestyle, rising prevalence of obesity, rising healthcare expenditure, and increasing cases of diabetes in the region
The major players in the market are Novo Nordisk A/S, DexCom, Inc., GlySens Incorporated, Medtronic plc, Insulet Corporation, Ypsomed Holding AG, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Tandem Diabetes Care, Inc., ForaCare, Inc.
